News articles about Proto Labs (NYSE:PRLB) have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Proto Labs earned a news impact score of 0.20 on Accern’s scale. Accern also gave headlines about the industrial products company an impact score of 46.0084522554947 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

These are some of the headlines that may have effected Accern Sentiment’s rankings:

Shares of Proto Labs (PRLB) traded up $1.20 during trading on Tuesday, hitting $107.00. The company’s stock had a trading volume of 216,658 shares, compared to its average volume of 135,738. Proto Labs has a one year low of $48.00 and a one year high of $113.05. The stock has a market cap of $2,820.00, a price-to-earnings ratio of 60.80, a PEG ratio of 2.37 and a beta of 1.08.

PRLB has been the topic of a number of recent analyst reports. Zacks Investment Research lowered Proto Labs from a “buy” rating to a “hold” rating in a research note on Wednesday, December 27th. Craig Hallum set a $92.00 price target on Proto Labs and gave the stock a “hold” rating in a research note on Monday, November 27th. Finally, Piper Jaffray Companies reissued a “hold” rating and set a $84.00 price target on shares of Proto Labs in a research note on Thursday, December 14th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Proto Labs presently has a consensus rating of “Hold” and an average price target of $86.50.

In other news, Director Rainer Gawlick sold 1,500 shares of the company’s stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $90.31, for a total transaction of $135,465.00. Following the completion of the sale, the director now directly owns 6,925 shares in the company, valued at approximately $625,396.75. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP John B. Tumelty sold 13,556 shares of the company’s stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $92.07, for a total value of $1,248,100.92. The disclosure for this sale can be found here. In the last three months, insiders have sold 19,556 shares of company stock worth $1,814,101. Corporate insiders own 7.78% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Proto Labs (PRLB) Stock Price” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.dailypolitical.com/2018/02/06/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-proto-labs-prlb-stock-price.html.

About Proto Labs

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Insider Buying and Selling by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.